Dapagliflozin 5mg and 10mg tablets will be moving from Category C to Category M in the September 2025 Drug Tariff. This comes after several manufacturers launched generic versions of Dapagliflozin tablets following the recent ruling by the UK Court of Appeal to invalidate AstraZeneca’s patent for the brand Forxiga®. Currently, all branded and generically written prescriptions
Read moreThe Department of Health and Social Care (DHSC) has published details of its ongoing work and plans to improve the management of medicines supply issues. This includes a commitment to consulting on the introduction of pharmacist flexibilities to supply alternatives when a medicine is in short supply. The new policy paper, Managing a robust and
Read moreThe National Patient Prescription Tracking Service (NPPTS) enables patients to access and track their prescriptions online through the NHS App or their NHS account (by logging in on the NHS website). NPPTS is a feature of the Electronic Prescription Service (EPS) that utilises a combination of Spine and Pharmacy IT supplier systems’ information to provide item and
Read moreThe NHS Business Services Authority (NHSBSA) has seen an increase in the number of prescriptions from patients using the “HRT only prescription prepayment certificate” prescription charge exemption category for products that are not covered by the HRT Prescription Prepayment Certificate (HRT PPC). In the 12 months between June 2024 and May 2025, the NHSBSA received over 200k
Read moreOpinions from pharmacy owners and LPCs across the country are being compiled, alongside inputs from national pharmacy organisations and results from ongoing sector polling, to inform Community Pharmacy England Committee discussions on negotiating priorities for 2026/27. The Committee will consider all inputs, alongside Community Pharmacy England’s own analysis, to inform positioning and objectives for the
Read moreFollowing representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the following July 2025 concessionary prices: Drug Pack size Previous price concession for July 2025 New price concession for July 2025 Fexofenadine 180mg tablets 30 £2.31 £4.10 Pioglitazone 45mg tablets 28 £25.25
Read moreMHRA Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd Drug alert number: EL(25)A/39 Date issued: 07 August 2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hours transdermal patches MSN/2025/048 Tier 2 – medium impact Date of issue: 06/08/2025 Progynova® TS 50micrograms/24hours and 100micrograms/24hours transdermal patches (once weekly estradiol patches) will be discontinued from late December 2025 and
Read moreMHRA Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma Drug alert number: EL(25)A/38 Date issued: 04 August 2025 LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing. DMRC reference number: DMRC-36306427 Company name: LEO
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 August 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Hydrocortisone 500microgram granules in capsules for opening Alkindi® 0.5 mg granules in capsules
Read more
